๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Use of a recombinant Trypanosoma cruzi protein antigen to monitor cure of Chagas disease

โœ Scribed by A.G. Guevara; A. Taibi; J. Alava; R.H. Guderian; A. Ouaissi

Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
320 KB
Volume
89
Category
Article
ISSN
0035-9203

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Use of the eie-recombinant-chagas-bioman
Use of the eie-recombinant-chagas-biomanguinhos kit to monitor cure of human chagasโ€™ disease
โœ Edimilson D. Silva; Valรฉria R.A. Pereira; Juliana A.S. Gomes; Virgรญnia Maria B. ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 32 KB

## Abstract We used the EIEโ€Recombinantโ€Chagasโ€Biomanguinhos kit (EIEโ€Rec kit) developed by the Oswaldo Cruz Foundation, Brazil, to monitor cure of chagasic patients who were treated during the acute phase of __T. cruzi__ infection. Treated patients were previously studied by parasitological and se

Chagas' disease: IgG isotypes against cy
Chagas' disease: IgG isotypes against cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens of Trypanosoma cruzi in chronic Chagasic patients
โœ A.F.A. Verรงosa; V.M.B. Lorena; C.L. Carvalho; M.F.A.D. Melo; M.G.A. Cavalcanti; ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 134 KB

## Abstract The wide range of clinical Chagas' disease manifestations, of which heart involvement is the most significant, because of its characteristics, frequency and consequences, and lack of treatment and cure, justify research in this area. Specific immunoglobulin G (IgG) antibody subclasses h

Changes in isotype composition and antig
Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease
โœ Eufrosina S. Umezawa; Maria Aparecida Shikanai-Yasuda; Anna Maria S. Stolf ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 915 KB

This report describes differences in humoral immune response of acute and chronic phases of human Chagas disease. The reactivities of IgG, IgM, and IgA anti-Trypanosoma cruzi antibodies in serum samples from both groups of patients were compared by enzyme-linked immunosorbent assay (ELISA) employing

Glycoconjugates of Trypanosoma cruzi: A
Glycoconjugates of Trypanosoma cruzi: A 74 kD antigen of trypomastigotes specifically reacts with lytic anti-ฮฑ-galactosyl antibodies from patients with chronic Chagas disease
โœ Igor C. Almeida; Greice M. Krautz; Antoniana U. Krettli; Dr. Luiz R. Travassos ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 1016 KB

Protective, lytic antibodies are believed to be correlated with active Pypanosoma cruzi infection. In patients with chronic infection, antibodies lysing trypomastigote forms recognize chiefly a-galactosyl structures at the parasite surface. The target molecules on cell-derived trypomastigotes that r